Kamran Tahamtanzadeh
@kamran-tahamtanzadeh-17a316a
Co-founder & CEO at Cellazon
Profile links
Experience
-
Co-Founder, President CEO
At Cellazon, we are dedicated to transforming the future of precision medicine by unlocking actionable insights from complex patient data using an AI-MachineLearning-enabled computational analysis platform to decipher signaling pathways from cell-to-cell communication in disease using Single Cell-RNA-Seq and any available Multiomics data for discovery of novel therapeutic targets and…
-
Business Consultant
Pioneering the Future of Cell-Based Cancer Therapeutics with CAP Technology. At Preverna, we stand at the cutting edge of oncological advancements, driven by our groundbreaking Chimeric Adaptor Protein (CAP) technology. Distinctly set apart from traditional CAR-T therapies, our CAP-T cells promise enhanced therapeutic efficacy and refined control for solid tumors.
- Additional experience 1
- Additional experience 2
Unlock the full profile in Super Carl
See full connection graph context, complete work history, and AI-assisted outreach workflows.